Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiang Cao
Institutions:
Xuzhou Medical College,
Zhengzhou University,
Affiliated Hospital of Xuzhou Medical College,
Henan Cancer Hospital
Observed institutions:
Xuzhou Medical College,
Zhengzhou University,
Affiliated Hospital of Xuzhou Medical College,
Henan Cancer Hospital
ORCID:
0000-0003-3767-9283
Observed ORCID:
0000-0003-3767-9283
OpenAlex ID:
A5043701523
BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares
2026
·
Xiaoyu Huang
, Zhouao Zhang
, et al.
·
Science Advances
·
19
PDF
Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients
2023
·
YaNan Zhang
, FengAn Liu
, et al.
·
Clinical and Experimental Medicine
·
11
[Influence of the Ratio of Peripheral Hemoglobin-to-Red Cell Distribution width on the Prognosis of Patients with Diffuse Large B-cell Lymphoma].
2022
·
Xue-Yan Dong
, Guo-Feng Tang
, et al.
·
PubMed
·
8
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma ( CLL / SLL ): Results from the phase 3 study BRUIN CLL ‐321
2026
·
Shuhua Yi
, Jiang Cao
, et al.
·
British Journal of Haematology
·
3
PDF
Nephrotoxicity of CAR-T therapy in patients with relapsed and refractory multiple myeloma
2025
·
Zihan Chen
, Yegan Chen
, et al.
·
International Urology and Nephrology
·
3
Peripheral blood inflammatory ratios predict efficacy and toxicity of CAR-T cell immunotherapy in relapsed/refractory multiple myeloma
2026
·
Peng Xu
, Can Huang
, et al.
·
Frontiers in Immunology
·
1
PDF
Efficacy and safety of chimeric antigen receptor T-cell therapy for plasma cell leukemia
2026
·
Chenyuan Hu
, Na Qi
, et al.
·
Haematologica
PDF
Show more works
View as search
Works count:
7
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type